<p>Clinical details of subjects. ALS, amyotrophic lateral sclerosis; F, female; g, grams; l, litre; n, Number; M, male; mo, months; y, years. Age, age of onset, duration of disease and total serum protein are indicated as mean ± standard deviation (SD).</p>‡<p>Duration of disease is the interval between appearance of first symptom of ALS and collection of sample.</p>†<p><i>One-way analysis of variance</i> (ANOVA) followed by Fisher’s least significant difference (LSD) <i>post hoc</i> analysis showed that mean age, mean disease duration and mean total serum protein did not differ significantly among the given conditions (p>0.05). ALS subjects were asked to provide all clinical details at the age of onset of disease.</p
<p>*across subgroups of ALS.</p><p>ALSFRS-R = revised Amyotrophic Lateral Sclerosis Functional Rat...
new pathophysiological insights and opportunities for diagnostic testing (4,6,7). Epidemiology of AL...
<p>For each tertile group, mean age is indicated below survival time mean value.</p
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>Abbreviations: PMA = progressive muscular atrophy, ALS = amyotrophic lateral sclerosis, N = numbe...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p><sup>a</sup>Fisher’s exact test refers to comparison between all ALS patients and healthy control...
<p>N = Number of subjects, Ln = natural log transform. EES score: 1 = defined as possible ALS, 2 = p...
<p>Values are mean ± standard deviation [range] or number (%). P<sup>1</sup> = differences between ...
<p>Numbers are mean ± standard deviation (range) or number. °Disease progression rate = (48-ALSFRS-r...
<p>M: male; F: Female. B: bulbar onset; L: limb onset; MFO: interval from the observation of initial...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
<p>Data are presented as mean ± standard deviation. Differences between groups are represented as <s...
Amyotrophic lateral sclerosis (ALS) is a disease of the motor neuron with poorly understood etiology...
<p>*across subgroups of ALS.</p><p>ALSFRS-R = revised Amyotrophic Lateral Sclerosis Functional Rat...
new pathophysiological insights and opportunities for diagnostic testing (4,6,7). Epidemiology of AL...
<p>For each tertile group, mean age is indicated below survival time mean value.</p
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
<p>Abbreviations: PMA = progressive muscular atrophy, ALS = amyotrophic lateral sclerosis, N = numbe...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p><sup>a</sup>Fisher’s exact test refers to comparison between all ALS patients and healthy control...
<p>N = Number of subjects, Ln = natural log transform. EES score: 1 = defined as possible ALS, 2 = p...
<p>Values are mean ± standard deviation [range] or number (%). P<sup>1</sup> = differences between ...
<p>Numbers are mean ± standard deviation (range) or number. °Disease progression rate = (48-ALSFRS-r...
<p>M: male; F: Female. B: bulbar onset; L: limb onset; MFO: interval from the observation of initial...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
<p>Data are presented as mean ± standard deviation. Differences between groups are represented as <s...
Amyotrophic lateral sclerosis (ALS) is a disease of the motor neuron with poorly understood etiology...
<p>*across subgroups of ALS.</p><p>ALSFRS-R = revised Amyotrophic Lateral Sclerosis Functional Rat...
new pathophysiological insights and opportunities for diagnostic testing (4,6,7). Epidemiology of AL...
<p>For each tertile group, mean age is indicated below survival time mean value.</p